RecruitingACTRN12605000037606
NIVOAD Study: Non Invasive Ventilation in Obstructive Airways Diseases Study
NIVOAD Study: Non Invasive Ventilation duration in Obstructive Airways Diseases Study
Sponsor
Dr Anthony Cross
Enrollment
192 participants
Start Date
Jun 1, 2005
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 18 Yearss
Plain Language Summary
Simplified for easier understanding
This study compares two types of breathing support masks (non-invasive ventilation, or NIV) used in the emergency department for people having a moderate to severe asthma or COPD attack. Both masks help push air into the lungs without needing a breathing tube. The study aims to find out which approach works best.
You may be eligible if:
- You are 18 years of age or older
- You are being treated in an emergency department for a moderate to severe flare-up of asthma or COPD (chronic obstructive pulmonary disease)
- Your breathing is laboured (rapid breathing, low oxygen levels, or difficulty speaking in full sentences)
- Your doctor has decided that non-invasive ventilation is needed
You may NOT be eligible if:
- You are too drowsy or confused to cooperate or protect your own airway
- Your breathing failure is caused by something other than asthma or COPD
- You have an untreated collapsed lung (pneumothorax)
- You need a breathing tube placed in your throat
- Your medical team has decided to withhold or withdraw treatment
Talk to your doctor about whether this trial might be right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
CPAP vs BiPAP The duration is unknown but it is estimated to be in the order of 120 minutes
CPAP vs BiPAP The duration is unknown but it is estimated to be in the order of 120 minutes
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000037606
Related Trials
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
NCT06664619163 locations
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
NCT070739507 locations
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222194 locations
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
NCT059378545 locations
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209183 locations